Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 66

1.

Left ventricular diastolic function as a possible predictor of severe carfilzomib-induced cardiovascular events.

Abe Y, Kobayashi T, Narita K, Kobayashi H, Kitadate A, Miura D, Takeuchi M, Matsue K.

Blood Adv. 2019 Jun 11;3(11):1725-1728. doi: 10.1182/bloodadvances.2019000247. No abstract available.

2.

Intraoperative Transthoracic Echocardiography for a Neonate Using an Adult Multiplane Transesophageal Echocardiography Probe.

Miura D, Yamada Y, Nakao M, Sakaguchi Y, Mizuno K.

A A Pract. 2019 May 15;12(10):382-384. doi: 10.1213/XAA.0000000000000972. No abstract available.

PMID:
31091202
3.

Improvement of Sensitivity and Reproducibility for Imaging of Endogenous Metabolites by Matrix-Assisted Laser Desorption/Ionization-Mass Spectrometry.

Morikawa-Ichinose T, Fujimura Y, Murayama F, Yamazaki Y, Yamamoto T, Wariishi H, Miura D.

J Am Soc Mass Spectrom. 2019 May 1. doi: 10.1007/s13361-019-02221-7. [Epub ahead of print]

PMID:
31044355
4.

Pretreatment CD38-positive regulatory T-cells affect the durable response to daratumumab in relapsed/refractory multiple myeloma patients.

Kitadate A, Kobayashi H, Abe Y, Narita K, Miura D, Takeuchi M, Matsue K.

Haematologica. 2019 Apr 19. pii: haematol.2019.219683. doi: 10.3324/haematol.2019.219683. [Epub ahead of print]

5.

Evaluation of the safety and efficacy of daratumumab outside of clinical trials.

Kobayashi H, Tsushima T, Terao T, Abe Y, Miura D, Narita K, Kitadate A, Takeuchi M, Matsue K.

Int J Hematol. 2019 Jun;109(6):665-672. doi: 10.1007/s12185-019-02648-4. Epub 2019 Apr 8.

PMID:
30963473
6.

Low hexokinase-2 expression-associated false-negative 18F-FDG PET/CT as a potential prognostic predictor in patients with multiple myeloma.

Abe Y, Ikeda S, Kitadate A, Narita K, Kobayashi H, Miura D, Takeuchi M, O'uchi E, O'uchi T, Matsue K.

Eur J Nucl Med Mol Imaging. 2019 Jun;46(6):1345-1350. doi: 10.1007/s00259-019-04312-9. Epub 2019 Mar 22.

PMID:
30903198
7.

Diagnostic and Prognostic Value of Using 18F-FDG PET/CT for the Evaluation of Bone Marrow Involvement in Peripheral T-Cell Lymphoma.

Abe Y, Kitadate A, Usui Y, Narita K, Kobayashi H, Miura D, Takeuchi M, Oʼuchi E, Oʼuchi T, Matsue K.

Clin Nucl Med. 2019 May;44(5):e336-e341. doi: 10.1097/RLU.0000000000002516.

PMID:
30889000
8.

N-terminal pro-brain natriuretic peptide reflects both left ventricular diastolic dysfunction and myeloma-related renal insufficiency and robustly predicts mortality in patients with symptomatic multiple myeloma.

Abe Y, Kobayashi T, Usui Y, Narita K, Kobayashi H, Kitadate A, Miura D, Takeuchi M, Matsue K.

Oncotarget. 2019 Feb 1;10(10):1160-1170. doi: 10.18632/oncotarget.26647. eCollection 2019 Feb 1.

9.

Pretreatment 18F-FDG PET/CT combined with quantification of clonal circulating plasma cells as a potential risk model in patients with newly diagnosed multiple myeloma.

Abe Y, Narita K, Kobayashi H, Kitadate A, Miura D, Takeuchi M, O'uchi E, O'uchi T, Matsue K.

Eur J Nucl Med Mol Imaging. 2019 Jun;46(6):1325-1333. doi: 10.1007/s00259-019-4275-5. Epub 2019 Jan 28.

PMID:
30687892
10.

Sensitivity and specificity of incisional random skin biopsy for diagnosis of intravascular large B-cell lymphoma.

Matsue K, Abe Y, Kitadate A, Miura D, Narita K, Kobayashi H, Takeuchi M, Enzan N, Tanaka A, Takeuchi K.

Blood. 2019 Mar 14;133(11):1257-1259. doi: 10.1182/blood-2018-11-887570. Epub 2019 Jan 15. No abstract available.

11.

Prevalence and clinical implications of t(11;14) in patients with amyloid light-chain amyloidosis with or without concurrent multiple myeloma.

Kobayashi H, Abe Y, Miura D, Narita K, Kitadate A, Takeuchi M, Matsue K.

Jpn J Clin Oncol. 2019 Feb 1;49(2):195-198. doi: 10.1093/jjco/hyy202.

PMID:
30608548
12.

Limited efficacy of high-dose methotrexate in patients with neurolymphomatosis.

Kobayashi H, Abe Y, Miura D, Narita K, Kitadate A, Takeuchi M, Matsue K.

Int J Hematol. 2019 Mar;109(3):286-291. doi: 10.1007/s12185-018-02586-7. Epub 2019 Jan 3.

PMID:
30604318
13.

Kinetic modeling and sensitivity analysis for higher ethanol production in self-cloning xylose-using Saccharomyces cerevisiae.

Fukuda A, Kuriya Y, Konishi J, Mutaguchi K, Uemura T, Miura D, Okamoto M.

J Biosci Bioeng. 2019 May;127(5):563-569. doi: 10.1016/j.jbiosc.2018.10.020. Epub 2018 Nov 24.

PMID:
30482500
14.

Cryoprotectant-free high-pressure cooling and dynamic nuclear polarization for more sensitive detection of hydrogen in neutron protein crystallography.

Tanaka I, Komatsuzaki N, Yue WX, Chatake T, Kusaka K, Niimura N, Miura D, Iwata T, Miyachi Y, Nukazuka G, Matsuda H.

Acta Crystallogr D Struct Biol. 2018 Aug 1;74(Pt 8):787-791. doi: 10.1107/S2059798318005028. Epub 2018 Jul 17.

15.

The PDR-type ABC transporters AtrA and AtrG are involved in azole drug resistance in Aspergillus oryzae.

Miura D, Sugiyama K, Ito A, Ohba-Tanaka A, Tanaka M, Shintani T, Gomi K.

Biosci Biotechnol Biochem. 2018 Oct;82(10):1840-1848. doi: 10.1080/09168451.2018.1497941. Epub 2018 Jul 16.

PMID:
30011258
16.

Visualizing Energy Charge in Breast Carcinoma Tissues by MALDI Mass-spectrometry Imaging Profiles of Low-molecular-weight Metabolites.

Torata N, Kubo M, Miura D, Ohuchida K, Mizuuchi Y, Fujimura Y, Hayakawa E, Kai M, Oda Y, Mizumoto K, Hashizume M, Nakamura M.

Anticancer Res. 2018 Jul;38(7):4267-4272. doi: 10.21873/anticanres.12723.

PMID:
29970560
17.

Thymidine Kinase 1 Loss Confers Trifluridine Resistance without Affecting 5-Fluorouracil Metabolism and Cytotoxicity.

Edahiro K, Iimori M, Kobunai T, Morikawa-Ichinose T, Miura D, Kataoka Y, Niimi S, Wakasa T, Saeki H, Oki E, Kitao H, Maehara Y.

Mol Cancer Res. 2018 Oct;16(10):1483-1490. doi: 10.1158/1541-7786.MCR-17-0686. Epub 2018 Jun 4.

PMID:
29866926
18.

Analysis of spatiotemporal metabolomic dynamics for sensitively monitoring biological alterations in cisplatin-induced acute kidney injury.

Irie M, Hayakawa E, Fujimura Y, Honda Y, Setoyama D, Wariishi H, Hyodo F, Miura D.

Biochem Biophys Res Commun. 2018 Jan 29;496(1):140-146. doi: 10.1016/j.bbrc.2018.01.012. Epub 2018 Jan 4.

PMID:
29307833
19.

Impact of the Oral Adsorbent AST-120 on Organ-Specific Accumulation of Uremic Toxins: LC-MS/MS and MS Imaging Techniques.

Sato E, Saigusa D, Mishima E, Uchida T, Miura D, Morikawa-Ichinose T, Kisu K, Sekimoto A, Saito R, Oe Y, Matsumoto Y, Tomioka Y, Mori T, Takahashi N, Sato H, Abe T, Niwa T, Ito S.

Toxins (Basel). 2017 Dec 28;10(1). pii: E19. doi: 10.3390/toxins10010019.

20.

A Phytochemical-Sensing Strategy Based on Mass Spectrometry Imaging and Metabolic Profiling for Understanding the Functionality of the Medicinal Herb Green Tea.

Fujimura Y, Miura D, Tachibana H.

Molecules. 2017 Sep 27;22(10). pii: E1621. doi: 10.3390/molecules22101621. Review.

Supplemental Content

Loading ...
Support Center